Albumedix announces evaluation agreement with a top pharma collaborator

Novartis and Albumedix Ltd. (‘Albumedix’) have entered into an agreement to evaluate the development of several first-in-class therapeutics using Albumedix’s Veltis®technology platform and associated technologies.

Novartis will evaluate molecules in combination with Albumedix´s engineered albumin variants for enhanced delivery. Beyond the modulation of pharmacokinetic profiles, the potential for novel routes of administration and mechanisms of action will be assessed. Novartis will evaluate Albumedix’s Veltis technology across multiple therapeutic areas and against multiple targets.

This collaboration is an excellent example of how our Veltis technology platform holds great potential for optimizing the therapeutic performance of pharmaceuticals across a broad range of targets and indications. We look forward to a strong collaboration with the various research teams at Novartis for the advancement of albumin-enabled therapeutics.”

Dr. Phil Morton, Chief Technology Officer, Albumedix

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Albumedix Ltd.. (2019, August 20). Albumedix announces evaluation agreement with a top pharma collaborator. News-Medical. Retrieved on July 06, 2020 from https://www.news-medical.net/news/20190820/Albumedix-announces-evaluation-agreement-with-a-top-pharma-collaborator.aspx.

  • MLA

    Albumedix Ltd.. "Albumedix announces evaluation agreement with a top pharma collaborator". News-Medical. 06 July 2020. <https://www.news-medical.net/news/20190820/Albumedix-announces-evaluation-agreement-with-a-top-pharma-collaborator.aspx>.

  • Chicago

    Albumedix Ltd.. "Albumedix announces evaluation agreement with a top pharma collaborator". News-Medical. https://www.news-medical.net/news/20190820/Albumedix-announces-evaluation-agreement-with-a-top-pharma-collaborator.aspx. (accessed July 06, 2020).

  • Harvard

    Albumedix Ltd.. 2019. Albumedix announces evaluation agreement with a top pharma collaborator. News-Medical, viewed 06 July 2020, https://www.news-medical.net/news/20190820/Albumedix-announces-evaluation-agreement-with-a-top-pharma-collaborator.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.